do glp 1 reduce cancer risk GLP-1s tied to lower for 10 types of compared with insulin in type 2 diabetes Glucagon-like peptide-1 receptor agonists and

India is home to over 100 million people with diabetes and approximately 250 million classified as obese or overweight.[15] What makes the situation uniquely dangerous is the Thin-Fat Indian paradox: South Asians tend to accumulate more visceral (belly) fat, liver fat, and less lean muscle mass at lower body weights than Western populations.[8][9][10] While GLP-1 medications are a global phenomenon, they are particularly critical for the Thin-Fat Indian phenotype

This decision should be made with a physician

LeWine, MD, Chief Medical Editor, Harvard Health Publishing

This approach may be especially useful for substances that gain rapid popularity online, including products sold in less regulated markets such as injectable peptides

Crafted with clinically studied ingredients including probiotics, prebiotics, vitamins, and herbs, SymptoGuard supports digestion, energy, and overall well-being

they can still mess with glucose balance